Latest Capital Raises News

Talius Group reports a robust December quarter with $4.4 million revenue, positive operating cash flow, and a strategic $2.5 million capital raise, positioning the company for strong growth in 2025 amid evolving aged care legislation.

Condor Energy Ltd has raised A$3 million through a well-supported placement to advance its exploration and commercialisation efforts in the Tumbes Basin offshore Peru, focusing on the promising Piedra Redonda gas discovery.

Peregrine Gold Limited has agreed to sell its Deadman Flat and Perry Creek Project to Capricorn Metals Ltd for A$1.5 million in shares, while maintaining upside through royalties and milestone payments. This deal strengthens Peregrine’s balance sheet and accelerates its focus on the Tin Can Trend exploration.

EP&T Global delivered a positive net operating cash inflow of $0.4 million in the December 2024 quarter, supported by an 11% increase in customer receipts and a $1 million private placement to back expansion plans.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Golden Horse Minerals has swiftly completed its inaugural drilling campaign at Hakes Find shortly after its ASX debut, setting the stage for an active exploration year in 2025.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

Forbidden Foods Limited has more than doubled its group revenues in Q2 FY25 following the acquisition of Oat Milk Goodness, driven by expanded retail distribution and strong ecommerce growth.

Insignia Financial has received a second revised indicative proposal from Bain Capital to acquire the company at A$4.60 per share, matching a rival bid and signaling a competitive acquisition process.

Firebrick Pharma has made notable progress expanding its Nasodine nasal spray in Singapore, securing major distribution and marketing agreements that set the stage for retail sales growth in 2025.

Sierra Nevada Gold's December 2024 quarterly report reveals promising high-grade silver intersections at its Blackhawk Epithermal Project, alongside a successful capital raise and strategic board appointment.